Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-09-16 Sale | 2024-09-16 5:13 pm | ALIMERA SCIENCES INC | ALIM | Morgan Adam Velan Capital Investment Management LP Velan Capital Master Fund LP Velan Capital SPV I LLC Velan Capital Holdings LLC Velan Capital Management LLC VENKATARAMAN BALAJI Director 10% Owner | 13,608,533 | $0 | $0 | 0 (Indirect Direct) | View |
2024-02-08 Purchase | 2024-02-09 8:40 pm | Jasper Therapeutics Inc. | JSPR | Velan Capital Investment Management LP Velan Capital Master Fund LP Avego Healthcare Capital L.P. Velan Capital Holdings LLC Avego Healthcare Capital Holdings LLC Avego Management LLC Velan Capital Management LLC VENKATARAMAN BALAJI Morgan Adam 10% Owner | 350,000 | $12.95 | $4,532,500 | 1,433,828 (Indirect) | View |
2023-07-21 Purchase | 2023-07-25 4:22 pm | HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director | 2,486,744 | $1.37 | $3,406,839 | 8,187,514 (Indirect Direct) | View |
2023-05-17 Purchase | 2023-05-19 5:17 pm | ALIMERA SCIENCES INC | ALIM | Morgan Adam Director 10% Owner | 1,401,901 | $1.7 | $2,383,232 | 2,482,596 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-01-31 Option Award(A) | 2025-02-04 5:37 pm | N/A 2035-01-31 | HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director | 53,850 | $0 | 7,092,421 (Direct) | View |
2025-01-30 Option Award | 2025-02-03 09:17 am | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director | 17,950 | $0 | 7,092,421 (Direct) | View |
2025-01-30 Option Award | 2025-02-03 09:17 am | N/A 2035-01-30 | HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director | 35,900 | $1.73 | 7,092,421 (Direct) | View |
2024-01-19 Option Award | 2024-01-19 9:04 pm | N/A 2034-01-19 | HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director | 97,633 | $0 | 7,122,256 (Direct) | View |
2023-10-02 Option Award | 2023-10-04 5:44 pm | N/A 2033-10-01 | ALIMERA SCIENCES INC | ALIM | Morgan Adam Velan Capital Investment Management LP Velan Capital Master Fund LP Velan Capital SPV I LLC Velan Capital Holdings LLC Velan Capital Management LLC VENKATARAMAN BALAJI Director 10% Owner | 50,000 | $0 | 13,658,533 (Direct) | View |
2023-08-15 Conversion | 2023-08-17 8:18 pm | N/A N/A | ALIMERA SCIENCES INC | ALIM | Morgan Adam Velan Capital Investment Management LP Velan Capital Master Fund LP Velan Capital SPV I LLC Velan Capital Holdings LLC Velan Capital Management LLC VENKATARAMAN BALAJI Director 10% Owner | 2,924,762 | $2.1 | 4,178,725 (Indirect) | View |
2023-08-15 Conversion | 2023-08-17 8:18 pm | N/A N/A | ALIMERA SCIENCES INC | ALIM | Morgan Adam Velan Capital Investment Management LP Velan Capital Master Fund LP Velan Capital SPV I LLC Velan Capital Holdings LLC Velan Capital Management LLC VENKATARAMAN BALAJI Director 10% Owner | 9,024,117 | $1.7 | 4,178,725 (Indirect) | View |
2023-08-15 Conversion | 2023-08-17 8:18 pm | N/A N/A | ALIMERA SCIENCES INC | ALIM | Morgan Adam Velan Capital Investment Management LP Velan Capital Master Fund LP Velan Capital SPV I LLC Velan Capital Holdings LLC Velan Capital Management LLC VENKATARAMAN BALAJI Director 10% Owner | 21,117 | $0 | 4,178,725 (Indirect) | View |
2023-05-17 Other | 2023-05-19 5:17 pm | N/A 2030-03-24 | ALIMERA SCIENCES INC | ALIM | Morgan Adam Director 10% Owner | 2,057,143 | $0 | 2,482,596 (Indirect) | View |
2023-03-26 Option Award | 2023-03-28 6:51 pm | N/A 2033-03-23 | ALIMERA SCIENCES INC | ALIM | Morgan Adam Director | 1,825 | $0 | 3,122,721 (Direct) | View |
Ownership | 2023-03-28 6:49 pm | N/A N/A | ALIMERA SCIENCES INC | ALIM | Morgan Adam Director | 0 | $0 | 3,114,896 (Indirect) | View |
2023-02-22 Option Award | 2023-02-24 7:20 pm | N/A 2033-02-22 | HERON THERAPEUTICS INC. | HRTX | Morgan Adam See Notes 2 & 3 | 265,151 | $0 | 4,765,151 (Direct) | View |
Ownership | 2023-02-08 6:26 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Velan Capital Investment Management LP Velan Capital Master Fund LP Velan Capital Holdings LLC Velan Capital Management LLC VENKATARAMAN BALAJI Morgan Adam See Footnote 2 | 0 | $0 | 4,500,000 (Indirect) | View |
Ownership | 2023-02-03 4:35 pm | N/A N/A | Jasper Therapeutics Inc. | JSPR | Velan Capital Investment Management LP Velan Capital Master Fund LP Avego Healthcare Capital L.P. Velan Capital Holdings LLC Avego Healthcare Capital Holdings LLC Avego Management LLC Velan Capital Management LLC VENKATARAMAN BALAJI Morgan Adam 10% Owner | 0 | $0 | 11,219,036 (Indirect) | View |